Published • loading... • Updated
Senseonics amends loan facility, ups borrowing capacity to $140M
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Senseonics amends loan facility, ups borrowing capacity to $140M
The Eversense E3 long-term implantable CGM. [Image courtesy of Senseonics]Senseonics (NYSE:SENS) announced today that it amended a loan and security agreement to increase its maximum borrowing capacity. The long-term implantable continuous glucose monitor (CGM) maker entered into the agreement with Hercules Capital. It increases its maximum borrowing capacity from $100 million to $140 million. In addition to $35 million of borrowings currently o…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
